GL1X · GenesisL1 explorer

MolNFT v1 · #183306 · protein

Crystal structure of dc-sign in complex with a triazole-based glycomimetic ligand

7NL7 · Dc-sign, crd domain: “Crystal structure of dc-sign in complex with a triazole-based glycomimetic ligand”. X-ray diffraction, 2 ligands (UH5, CA). MolNFT v1 #183306 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7NL7
Type
protein
Length
132 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dc-sign, crd domain
UniProt
Q9NNX6
Ligands
UH5, CA

Structure

x-ray diffraction · 1 distinct chain · 23% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADc-sign, crd domainprotein13223% helix, 34% strandQ9NNX6

Ligands and binding sites

  • UH5 · 3-Aminopropyl 2-deoxy-2-(4-phenyl-1,2,3-triazol-1-yl)-alpha-D-mannopyranoside · ligand · chains A
  • CA · Calcium ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 7NL7 · Crystal Structure of DC-SIGN in complex with a triazole-based glycomimetic ligand · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NNX6 · AlphaFold monomer V2.0 prediction for CD209 antigen (Q9NNX6) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.